Human serum albumin, 2 ml/vial

許可證數量: 1

Recombinant human CRP in a stabilized protein martrix, 1 ml/vial

許可證數量: 1

Bisoprolol Fumarate contains not less than 97.5% of (C18H31NO4)2？C4H4O4 calculated on anhydrous basis.

許可證數量: 1

Dicyclomine Hydrochloride contains not less than 99.0% and not more than 101.0% of C19H35NO2, HCL, calculated with reference to the dried substance.

許可證數量: 1

Lansoprazole contains not less than 99.0% and not more than 101.0% of C16H14F3N3O2S, calculated on the anhydrous basis.

許可證數量: 1

TRIPROLIDINE HCL

許可證數量: 60

3test Blood Glucose Test Strips: 13% glucose oxidase, 67% potassium ferricyanide, 20% non-active ingredients Glucose Standard Solutions: 250 mg/dL of glucose

許可證數量: 1

乾蠍

許可證數量: 3

烏喙

許可證數量: 3

烏蛇

許可證數量: 3

豬脂加至

許可證數量: 3

頭醋

許可證數量: 3

ANTHRALIN (DITHRANOL)

許可證數量: 9

CLOSTRIDIUM BOTULINUM TYPE A TOXIN-HAEMAGGLUTININ COMPLEX

許可證數量: 1

SULFADIAZINE SILVER

許可證數量: 38

Gold chloride Trihydrate 0.0206 mg, Potassium carbonate 0.001 mg, Sodium citrate tribasic dehydrate 0.025 mg, New born Calf Serum 0.02 mg, Tween 20 0.06 mg, Sodium Chloride 0.8 mg, NaH2HPO4．H2O 0.001 mg, Na2HHPO4 0.001 mg, Go

許可證數量: 1

Gold chloride Trihydrate 0.0266 mg, Potassium carbonate 0.001 mg, Sodium citrate tribasic dehydrate 0.025 mg, New born Calf Serum 0.02 mg, Tween 20 0.06 mg, Sodium Chloride 0.08 mg, NaH2HPO4．H2O 0.001 mg, Na2HHPO4 0.001 mg, G

許可證數量: 1

ST535SHG 無色透明3.5 ml用噴霧30 μL (肝素鈉)，用分離膠0.6g (聚烯烴樹脂AP-TC)、 ST530SHG 無色透明3 ml用噴霧30 μL (肝素鈉)，用分離膠0.6g (聚烯烴樹脂AP-TC)、 ST520SHG 無色透明2 ml用噴霧30 μL (肝素鈉)，用分離膠0.6g (聚烯烴樹脂AP-TC)、 ST750SHG 無色透明5 ml用噴霧30 μL (肝素鈉)，用分離膠0.9g (聚烯烴樹脂AP-TC)、 ST7

許可證數量: 1

櫻花油

許可證數量: 1

Oxalate Reagent A Oxalate Reagent B Sample diluent Sample purifier tubes Oxalate urine controls Elevated Oxalate urine controls Normal Oxalate Standard

許可證數量: 1

Cephradine has a potency of not less than 900 ug of C16H19N3O4S per mg, calculated on the anhydrous basis.

許可證數量: 1

PHENYTOIN SODIUM, contains not less than 98.5% and not more than 100.5% of C15H11N2NaO2, calculated on the dried basis.

許可證數量: 1

1.Coated Tubes: tubes coated with anti CA 15-3 monocloanl antibodies. 2.TSH tracer: Anti-CA 15-3-125I (monoclonal antibodies) in phosphate buffer with bovine serum, azide (＜0.1%), and inert red dye. 3.TSH Calibratosr: Calibra

許可證數量: 1

LAPATINIB DITOSYLATE MONOHYDRATE

許可證數量: 1

This product is prepared from human serum with added constituents of human and animal origin, preservatives and stabilizers. The control is provided in liquid form for convenience.

許可證數量: 1

Roche/Hitachi Tina quant Myoglobin Gen.2: R1 Glycine buffer: 170 mmol/L, pH 8.3; NaCl: 100 mmol/L; EDTA: 50 mmol/L; preservative R2 Latex particles coated with anti-human myoglobin antibodies (rabbit): 0.1%; glycine buffer: 1

許可證數量: 1

1. HTLV Microplate 2. Non-Reactive Control: Normal human serum 3. Reactive Control: Inactivated human serum containing a high titer of IgG antibodies specific for HTLV 4. Diluent: Phosphate buffer saline solution containin

許可證數量: 1

Reagents - working solutions R1 Vancomycin labeled with bacterial G6PDH in buffer R2 Anti-vancomycin antibody (mouse monoclonal), G6P and NAD in buffer

許可證數量: 1

Reagents - working solutions R1 Anti-valproic acid antibody (mouse monoclonal), G6P, NAD and bovine serum albumin in buffer R2 Valproic acid labeled with bacterial G6PDH, and bovine serum albumin in buffer

許可證數量: 1

Reagents - working solutions R1 Antibody Working Solution Benzodiazepines antibody (sheep polyclonal) in buffer with bovine serum albumin and 0.09% sodium azide R2 Microparticle Working Solution Conjugate

許可證數量: 1

Reagents - working solutions R1 Buffer; 0.09% sodium azide R2 Propoxyphene antibody (goat polyclonal); buffer; bovine serum albumin; 0.09% sodium azide R3 Conjugated propoxyphene derivative microparticles; buffer; 0.09% sodiu

許可證數量: 1

Capture-R Ready-Screen(3) consisting of 1x8 strips of wells carrying the bound and dried red blood cell membranes of three different group O donors, respectively (and a fourth positive control well coated with IgG sensitized

許可證數量: 1

Human serum, human CRP, 1.0ml/vial

許可證數量: 1

Lyophilized human serum, 0.85g/vial

許可證數量: 1

甘松草

許可證數量: 2

HYDROXYETHYL STARCH (200/0.5)

許可證數量: 2

Meprobamate contains 97.0%~101.0% (dried basis)

許可證數量: 1

Reagent - working solutions R1 Antibody/substrate reagent Anti-procainamide antibody (mouse monoclonal), G6P, NAD, preservatives and stabilizers R2 Enzyme reagent Procainamide labeled with bacterial G6PDH in buffer

許可證數量: 1

Reagents - working solutions R1 Buffer; 0.09% sodium azide R2 Amphetamine and methamphetamine antibodies (mouse monoclonal); buffer; bovine serum albumin; 0.09% sodium azide R3 Conjugated amphetamine derivative microparticles

許可證數量: 1

Reagents - working solutions R1 Buffer; 0.09% sodium azide R2 Secobarbital antibody (sheep polyclonal); buffer; bovine serum albumin; 0.09% sodium azide R3 Conjugated secobarbital derivative microparticles; buffer; 0.09% sodi

許可證數量: 1

Microparticles: 1 Bottle (6.6 mL per 100 test bottle/27.0 mL per 500 test bottle) Anti-tacrolimus coated microparticles in EDTA buffer with protein stabilizer. Minimum Concentration: 0.09% solids. Preservatives: sodium azide

許可證數量: 1

SODIUM PHOSPHATE DIBASIC. 12H2O

許可證數量: 1

1.分型試劑盤 (Typing Tray)，每盤供12個反應使用，共2盤 每個分型試劑盤可供12個樣本測試使用，包括乾燥引子之聚合酶鏈鎖反應試管。 2.Master緩衝液 (Master Buffer)，每管1040 μl，共3管 提供聚合酶鏈鎖反應之最適化緩衝液，成份包含0.18mM去氧核苷酸(dNTP), 1.8mM氯化鎂(MaCl2). 60.3mM 氯化鉀(KCl), 18.9mM三羥甲基氨基甲烷

許可證數量: 1

1.分型試劑盤 (Typing Tray)，每盤供96個反應使用，1盤 包括乾燥引子之聚合酶鏈鎖反應試管。 2.Master緩衝液 (Master Buffer)，每管1040 μl，共2管 包含0.18mM去氧核苷酸(dNTP), 1.8mM氯化 鎂(MgCl2). 60.3mM 氯化鉀(KCl), 18.9mM三羥甲基氨基甲烷鹽酸鹽(Tris-HCl)及0.6%甘油(glycerol)。 3.聚合酶鏈

許可證數量: 1

ALIMEMAZINE (AS ALIMEMAZINE TARTRATE)

許可證數量: 1

Elecsys PAPP-A Reagent - working solutions M Streptavidin-coated microparticles(transparent cap), 1 bottle, 6.5 mL: Streptavidin-coated microparticles 0.72 mg/mL; preservative. R1 Anti-PAPP-A-Ab~biotin (gray cap), 1 bottle, 9

許可證數量: 1

Goat anti-mouse-IgG(14%), Morphine-BSA(20%), MAb anti-Morphine CGC(23%)

許可證數量: 1

Human serum with added therapeutic drugs, preservative and stabilizer.

許可證數量: 1

Reagent - working solutions R1 TRIS buffer: 20 mmol/L, pH 8.0; NaCl: 200 mmol/L; polyethylene glycol: 3.6%; preservative; stabilizers R2 Anti-human IgG antibody (goat): dependent on titer; TRIS buffer: 20 mmol/L, pH 8.0; NaCl

許可證數量: 1

Strip：Glucose oxidase 10%、Electron shuttle 50%、Enzyme protector 8%、Non-reactive ingredients 32% Control：D-Glucose 0.03-0.30%、Inert ingredient > 99.7%

許可證數量: 1